---
$id: https://graph.org.ai/products/commodity/51111841
$type: Product
source: UNSPSC
code: "51111841"
title: "Cioteronel"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cioteronel

**UNSPSC Code**: 51111841
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C16H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RTH95874Z, chemically known as 1,5-cis-verknupften but generally known as cioteronel, which bears US NIH Compound Identifier 55994. European Medicines Agency schedules Cioteronel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06319MIG. The term CIOTERONEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). CIOTERONEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cioteronel under HS 29372900 and SITC 54153. As of Q4 2014, CIOTERONEL remains the US FDA Preferred Term for this commodity. Cioteronel bears US NLM identifiers UMLS ID C0625429 and NCI Concept Code C74119. SMILES: O=C1CC2C(CCC2CCCCC(OC)CC)C1.

